{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:01:37Z","timestamp":1792544497750,"version":"4.5.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2834,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1365-2133.2007.08332.x","type":"journal-article","created":{"date-parts":[[2010,7,21]],"date-time":"2010-07-21T16:31:54Z","timestamp":1279729914000},"page":"370-374","source":"Crossref","is-referenced-by-count":81,"title":["Long-term efficacy of a single course of infliximab in hidradenitis suppurativa"],"prefix":"10.1093","volume":"158","author":[{"given":"J.R.","family":"Mekkes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,11,28]]},"reference":[{"key":"10.1111\/j.1365-2133.2007.08332.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1046\/j.1468-3083.2001.00303.x","article-title":"Acne inversa (alias hidradenitis suppurativa)","volume":"15","author":"Jansen","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2007.08332.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/120347540300700109","article-title":"Hidradenitis suppurativa","volume":"7","author":"Jemec","year":"2003","journal-title":"J Cut Med Surg"},{"key":"10.1111\/j.1365-2133.2007.08332.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaad.2006.08.061","article-title":"Quality of life impairment in hidradenitis suppurativa: a study of 61 cases","volume":"56","author":"Wolkenstein","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08332.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0007-1226(03)00177-2","article-title":"Hidradenitis suppurativa: pathogenesis and management","volume":"56","author":"Slade","year":"2003","journal-title":"Br J Plast Surg"},{"key":"10.1111\/j.1365-2133.2007.08332.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0190-9622(98)70272-5","article-title":"A randomised trial of topical clindamycin vs. systemic tetracycline in hidradenitis suppurativa","volume":"39","author":"Jemec","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08332.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.exer.2006.02.004","article-title":"Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye","volume":"83","author":"De Paiva","year":"2006","journal-title":"Exp Eye Res"},{"key":"10.1111\/j.1365-2133.2007.08332.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/art.21620","article-title":"Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone","volume":"54","author":"O\u2019Dell","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2007.08332.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s10227-005-0110-7","article-title":"Off-label dermatologic uses of anti-TNF-a therapies","volume":"9","author":"Alexis","year":"2005","journal-title":"J Cutan Med Surg"},{"key":"10.1111\/j.1365-2133.2007.08332.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00054725-200111000-00008","article-title":"Hidradenitis suppurativa and Crohn\u2019s disease: response to treatment with infliximab","volume":"7","author":"Martinez","year":"2001","journal-title":"Inf Bowel Dis"},{"key":"10.1111\/j.1365-2133.2007.08332.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1111\/j.1572-0241.2002.05950.x","article-title":"Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn\u2019s disease patient","volume":"97","author":"Katsanos","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2133.2007.08332.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1007\/s00535-003-1185-9","article-title":"Hidradenitis suppurativa associated with Crohn\u2019s disease and spondyloarthropathy: response to anti-TNF therapy","volume":"38","author":"Roussomoustakaki","year":"2003","journal-title":"J Gastroenterol"},{"issue":"Suppl. 5","key":"10.1111\/j.1365-2133.2007.08332.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"S275","DOI":"10.1016\/S0190-9622(03)01132-0","article-title":"Infliximab for the treatment of hidradenitis suppurativa","volume":"49","author":"Lebwohl","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08332.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/j.1365-2133.2003.05663.x","article-title":"Infliximab for hidradenitis suppurativa","volume":"149","author":"Sullivan","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08332.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1001\/archderm.139.12.1540","article-title":"Severe hidradenitis suppurativa treated with infliximab infusion","volume":"139","author":"Adams","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08332.x-BIB15|cit15","first-page":"196","article-title":"Treatment of suppurative hidradenitis with surgical deroofing and infliximab","volume":"14","author":"Mekkes","year":"2004","journal-title":"Ned Tijdschr Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2007.08332.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1365-2133.2006.07528.x","article-title":"Long-term infliximab for severe hidradenitis suppurativa","volume":"154","author":"Thielen","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08332.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1365-2133.2005.07067.x","article-title":"Etanercept: effective in the management of hidradenitis suppurativa","volume":"154","author":"Cusack","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08332.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2340\/00015555-0046","article-title":"Severe acne successfully treated with etanercept","volume":"86","author":"Campione","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2133.2007.08332.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/archderm.142.9.1110","article-title":"Severe hidradenitis suppurativa treated with adalimumab","volume":"142","author":"Moul","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08332.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-2133.2003.05390.x","article-title":"Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa","volume":"149","author":"Sartorius","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08332.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1365-2133.2001.04137.x","article-title":"Morbidity in patients with hidradenitis suppurativa","volume":"144","author":"Von der Werth","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08332.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/archderm.138.9.1221","article-title":"The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review","volume":"138","author":"De Korte","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08332.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000018126","article-title":"Cigarette smoking as a triggering factor of hidradenitis suppurativa","volume":"198","author":"Konig","year":"1999","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2007.08332.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.surg.2005.06.053","article-title":"Surgical treatment of hidradenitis suppurativa: a 10-year experience","volume":"138","author":"Kagan","year":"2005","journal-title":"Surgery"},{"key":"10.1111\/j.1365-2133.2007.08332.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1600-0625.2006.00476.x","article-title":"Dioxin-induced chloracne - reconstructing the cellular and molecular mechanisms of a classic environmental disease","volume":"15","author":"Panteleyev","year":"2006","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08332.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1158\/0008-5472.CAN-05-4541","article-title":"High levels of dioxin-like potential in cigarette smoke evidenced by in vitro and in vivo biosensing","volume":"66","author":"Kasai","year":"2006","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2133.2007.08332.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1002\/art.22214","article-title":"Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab","volume":"54","author":"Bendtzen","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2007.08332.x-BIB28|cit28","first-page":"280","article-title":"Methotrexate is of limited value in the treatment of hidradenitis suppurativa","volume":"47","author":"Jemec","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08332.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1477-7525-4-71","article-title":"The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study","volume":"4","author":"Shikiar","year":"2006","journal-title":"Health Qual Life Outcomes"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2007.08332.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2007.08332.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:23:37Z","timestamp":1676384617000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/158\/2\/370\/6641603"}},"subtitle":["Infliximab in hidradenitis suppurativa"],"short-title":[],"issued":{"date-parts":[[2007,11,28]]},"references-count":29,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08332.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,28]]}}}